Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FREED: Febuxostat for Prevention of Cerebral and Cardiorenovascular Events in Hyperuricemia
NCT01984749Phase 4Unknown
- Sponsor
- FREED Study Group
- Start
- Nov 2013
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of febuxostat in hyperuricemia, sponsored by FREED Study Group. Status: unknown.
02
Drugs
febuxostat
03
Conditions
hyperuricemia
Beyond the preview
Go deeper on NCT01984749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01984749.